benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide has been researched along with oxotremorine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howard, MD; Karanth, S; Mirajkar, N; Pope, CN | 1 |
1 other study(ies) available for benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n-dimethyl-n-2-propenyl-), dibromide and oxotremorine
Article | Year |
---|---|
Comparative effects of oral chlorpyrifos exposure on cholinesterase activity and muscarinic receptor binding in neonatal and adult rat heart.
Topics: Administration, Oral; Age Factors; Animals; Animals, Newborn; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Chlorpyrifos; Cholinesterases; Female; Heart; Inhibitory Concentration 50; Male; Muscarinic Agonists; Myocardium; Oxotremorine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Tetraisopropylpyrophosphamide; Weight Gain; Weight Loss | 2007 |